Abstract

Developing digital devices and remote technologies for the diagnosis and management of arrhythmias are revolutionizing cardiologist clinical practice and decision-making. Electrocardiogram (ECG) and plethysmography (PPG)-based devices are widely used to assess cardiac rhythm. Artificial intelligence (AI) enabled devices may contribute to early detection and monitoring of atrial fibrillation (AF), long QT syndrome (LQTS), as well as QTc related adverse drug events. Some other devices such as contactless rhythm monitoring may be useful in ambulatory cardiac arrhythmia mass screening. Keywords Digital device ;Arrhythmia ;Atrial fibrillation ;Artificial intelligence ;Review.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call